The Main man23 May 2020 17:39
Mr. Cerrone served as a director of Inhibitex, Inc. until its US$2.5bn sale to Bristol Myers Squibb Co in 2012. Mr. Cerrone is the Executive Chairman and Co-Founder of Gensignia Life Sciences, Inc., a molecular diagnostics company focused on oncology using microRNA technology; Chairman and Founder of Tiziana Life Sciences plc an oncology focused therapeutics company; Chairman and Co-Founder of Rasna Therapeutics Limited, a company focused on the development of therapeutics for leukaemias; Co-Founder of ContraVir Pharmaceuticals, Inc. and founder of BioVitas Capital Ltd.
You can throw ever conundrum why we are de merging.But I would imagine he has some clue what he’s doing as above.
My opinion is he’s just protecting the unfinished worth in tils it’s something close to him personally and the StemPrintER success could stop him finishing what he started.
He’s know the worth of StemPrintER and removing it from the portfolio to be sold before a hostile takeover.
Ps I’ve a an inkling this is going to happen very quickly imo gla